By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biosearch Technologies said today that it has won an $800,000 grant from the US Department of Defense to design and develop rapid and accurate assays for testing of hazardous pathogens.

The DoD Small Business Innovation Research grant will be used to develop reverse transcriptase quantitative PCR assays for field deployment in overseas military operations, the Novato, Calif.-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.